Induction of anti-simian immunodeficiency virus cellular and humoral immune responses in rhesus macaques by peptide immunogens: Correlation of CTL activity and reduction of cell-associated but not plasma virus load following challenge

Journal of General Virology

Volumn 83, Issue 1, 2002, Pages 81-91

  Vogel, T U ^a   Beer, B E ^a   Zur Megede, J ^a   Ihlenfeldt, H G ^a   Jung, G ^a   Holzammer, S ^a   Watkins, D I ^a   Altman, J D ^a   Kurth, R ^a   Norley, S ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; CARRIER PROTEIN; CD8 ANTIGEN; CYSTEINE; EPITOPE; HYBRID PROTEIN; IMMUNOLOGICAL ADJUVANT; LIPOPEPTIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NEUTRALIZING ANTIBODY; RNA; SERINE; TETRAMER; TRIPALMITIN;

ACTIVE IMMUNIZATION; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CORRELATION FUNCTION; CYTOTOXIC LYMPHOCYTE; HUMORAL IMMUNITY; IMMUNOGENICITY; INFECTION PREVENTION; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; SEQUENCE HOMOLOGY; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE ACTIVATION; VACCINE PRODUCTION; VIREMIA; VIRUS INFECTION; VIRUS LOAD;

ANIMALIA; MACACA; MACACA MULATTA; RNA VIRUSES; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0036138290     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-83-1-81     Document Type: Article

References (60)

1. Rapid induction of primary human CD4+ and CD8+ T cell responses against cancer-associated MUC1 peptide epitopes
2. Antiviral cytotoxic T-cell response induced by in vivo priming with a free synthetic peptide
3. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2
4. + lymphocytes from simian immunodeficiency virus infected rhesus macaques recognize 14 different epitopes bound by the major histocompatibility complex class 1 molecule mamu-A*01: Implications for vaccine design and testing
5. Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-A*01) that binds an immuno-dominant CTL epitope from simian immunodeficiency virus
6. Phenotypic analysis of antigen-specific T lymphocytes
7. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination
8. Identification of a neutralizing domain in the external envelope glycoprotein of simian immunodeficiency virus
9. Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees
10. HIV env glycoprotein shares a cross-reacting epitope with a surface protein present on activated human monocytes and involved in antigen presentation
11. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus
12. Three epitopic peptides of the simian immunodeficiency virus Nef protein recognized by macaque cytolytic T lymphocytes
13. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide
14. Macromolecular assemblage in the design of a synthetic AIDS vaccine
15. Vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine
16. Limiting dilution analysis of in vivo-activated (IL-2 responsive) peripheral blood lymphocytes in HIV-1-infected subjects
17. Prime-boost immunization with DNA vaccine: Mucosal route of administration changes the rules
18. Virus-specific cytotoxic T-lymphocyte responses select for amino acid variation in SIV Env and Nef
19. Definition of five new simian immunodeficiency virus cytotoxic T-lymphocyte epitopes and their restricting major histocompatibility complex class 1 molecules: Evidence for an influence on disease progression
20. Long-lived cytotoxic T lymphocyte memory in mucosal tissues after mucosal but not systemic immunization
21. Early suppression of SIV replication by CD8+ Nef-specific cytotoxic T cells in vaccinated macaques
22. Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen
23. Priming of anti-human immunodeficiency virus (HIV) CD8+ cytotoxic T cells in vivo by carrier-free HIV synthetic peptides
24. + T lymphocytes in semen of chronically infected rhesus monkeys by cell staining with a tetrameric major histocompatibility complex class 1- peptide complex
25. Protection against lethal Sendal virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide
26. Identification of two neutralizing and 8 non-neutralizing epitopes on simian immunodeficiency virus envelope using monoclonal antibodies
27. Analysis of Gag-specific cytotoxic T lymphocytes in simian immunodeficiency virus-infected rhesus monkeys by cell staining with a tetrameric major histocompatibility complex class l-peptide complex
28. Comparative analysis of cytotoxic T lymphocytes in lymph nodes and peripheral blood of simian immunodeficiency virus-infected rhesus monkeys
29. A synthetic analogue of Escherichia coli lipoprotein, tripalmitoyl pentapeptide, constitutes a potent immune adjuvant
30. The hepatitis B virus-specific CTL responses induced in humans by lipopeptide vaccination are comparable to those elicited by acute viral infection
31. Definition of an epitope and MHC class I molecule recognized by Gag-specific cytotoxic T lymphocytes in SIVmac-infected rhesus monkeys
32. + T-cell help is required for induction of antipeptide multispecific cytotoxic T lymphocytes by a lipopeptidic vaccine in rhesus macaques
33. A chemically defined synthetic vaccine model for HIV-1
34. AIDS vaccination
35. Insufficient inactivation of HIV-1 in human cryo poor plasma by β-propriolactone: Results from a highly accurate virus detection method
36. A novel method for producing anti-peptide antibodies. Production of site-specific antibodies to the T cell antigen receptor beta-chain
37. Lipopeptides of the N-terminus of Escherichia coli lipoprotein: Synthesis, mitogenicity and properties in monolayer experiments
38. Sequence homology between acquired immunodeficiency syndrome virus envelope protein and interleukin 2
39. A human immunodeficiency virus type 1 (HIV-1) infection-enhancing factor in seropositive sera
40. Antibodies to the primary immunodominant domain of human immunodeficiency virus type 1 (HIV-1) glycoprotein gp41 enhance HIV-1 infection in vitro
41. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase
42. Rapid in vivo induction of HIV-specific CD8+ cytotoxic T lymphocytes by a 15-amino acid unmodified free peptide from the immunodominant V3-loop of GP120
43. Efficiency of peptides and lipopeptides for in vivo priming of virus-specific cytotoxic T cells
44. Vaccine-induced neutralizing antibodies directed in part to the simian immunodeficiency virus (SIV) V2 domain were unable to protect rhesus monkeys from SIV experimental challenge
45. Recombinant modified vaccinia virus Ankara-simian immunodeficiency virus gag pol elicits cytotoxic T lymphocytes in rhesus monkeys detected by a major histocompatibility complex class I/peptide tetramer
46. Synthetic peptide vaccine design: Synthesis and properties of a high-density multiple antigenic peptide system
47. A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers
48. An epitope on the surface envelope glycoprotein (gp130) of simian immunodeficiency virus (SIVmac) involved in viral neutralization and T cell activation
49. Structural probing of human lutropin using antibodies raised against synthetic peptides constructed by classical and multiple antigen peptide system approaches
50. Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection
51. Autoimmune response in AIDS
52. Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans
53. The majority of neutralizing Abs in HIV-1-infected patients recognize linear V3 loop sequences. Studies using HIV-1MN multiple antigenic peptides
54. Rapid screening for Mamu-A1-positive rhesus macaques using a SIVmac Gag peptide-specific cytotoxic T-lymphocyte assay
55. Long-term high-titer neutralizing activity induced by octameric synthetic HIV-1 antigen
56. A synthetic peptide induces long-term protection from lethal infection with herpes simplex virus 2
57. Major histocompatibility complex class I molecules of nonhuman primates
58. Synthesis of the mitogenic S-{2,3-Bis(palmitoyloxy)propyl}-N-palmitoylpentapeptide from E. coli lipoprotein
59. Studies of cloned simian immunodeficiency virus-specific T lymphocytes. Gag-specific cytotoxic T lymphocytes exhibit a restricted epitope specificity
60. HIV and HLA similarity